
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Olivier Litzka, Partner at Andera Partners, talks about what it really takes for biotech companies to attract capital, stay focused, and survive the moments when biology and execution punch back. Olivia also discusses a collaborative effort in Europe to create a stronger public market and investor base, and what the emergence of AI and Chinese biotech means for building tomorrow's biotec...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Biotech Finance And Investor Update With Independent Board Director Allan Shaw

Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig

Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil

Getting To A First Product Approval With Celcuity's Brian Sullivan
Free AI-powered recaps of Business Of Biotech and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.